News
10d
Zacks Investment Research on MSNWill United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...
RAYMOND DWEK, a director at $UTHR, sold 3,000 shares of the company on 04-14-2025 for an estimated $855,480. We received data on the trade from a recent SEC filing ...
7d
Zacks Investment Research on MSNHere's Why United Therapeutics (UTHR) is a Strong Value StockIt doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Liquidia's collaboration with Sandoz and development of new products like L606 show promise. Learn why LQDA stock is a Hold.
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands ...
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
United Therapeutics (UTHR) announced that ten posters and presentations across its commercial and development portfolio will be presented at ...
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in United Therapeutics Corp (Symbol: UTHR), where a total of 2,163 contracts have traded ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results